Novo Nordisk: Final approval for Tresiba and Ryzodeg in Europe - progressive launch expected

NEUTRAL, Fair Value DKK1000 (+1%)

News published on January Tuesday 22, 2013
Share on

The Essentials

Everything you need to know about investment banking dedicated to growth
Stay Informed
Get our news
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities